X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (53) 53
metallurgy (52) 52
organic chemistry (48) 48
human necessities (46) 46
hygiene (46) 46
medical or veterinary science (46) 46
humans (45) 45
preparations for medical, dental, or toilet purposes (44) 44
specific therapeutic activity of chemical compounds ormedicinal preparations (41) 41
female (36) 36
index medicus (34) 34
male (33) 33
aged (29) 29
middle aged (28) 28
heterocyclic compounds (27) 27
acyclic or carbocyclic compounds (20) 20
adult (20) 20
climate change mitigation technologies in the production orprocessing of goods (17) 17
general tagging of cross-sectional technologies spanning over several sections of the ipc (17) 17
general tagging of new technological developments (17) 17
hematology (17) 17
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (17) 17
technologies or applications for mitigation or adaptation againstclimate change (17) 17
oncology (15) 15
aged, 80 and over (11) 11
essential thrombocythemia (11) 11
prognosis (11) 11
medicine, general & internal (9) 9
treatment outcome (9) 9
analysis (8) 8
care and treatment (8) 8
hungary (8) 8
therapy (8) 8
diagnosis (7) 7
follow-up studies (7) 7
hungary - epidemiology (7) 7
survival (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
measuring (6) 6
mutation (6) 6
pathology (6) 6
physics (6) 6
polycythemia-vera (6) 6
polymerase chain reaction (6) 6
risk factors (6) 6
testing (6) 6
anemia (5) 5
arrangements for measuring two or more variables not coveredin a single other subclass (5) 5
arrangements, systems or apparatus for checking not providedfor elsewhere (5) 5
calculating (5) 5
checking-devices (5) 5
chemotherapy (5) 5
clinical trials (5) 5
computing (5) 5
counting (5) 5
disease-free survival (5) 5
electric digital data processing (5) 5
generating random numbers (5) 5
hydroxyurea (5) 5
measuring not specially adapted for a specific variable (5) 5
measuring or testing not otherwise provided for (5) 5
myeloproliferative disorders - genetics (5) 5
patients (5) 5
polycythemia vera (5) 5
predictive value of tests (5) 5
registering or indicating the working of machines (5) 5
registry (5) 5
remission induction (5) 5
risk assessment (5) 5
rituximab (5) 5
survival rate (5) 5
tariff metering apparatus (5) 5
time or attendance registers (5) 5
voting or lottery apparatus (5) 5
adolescent (4) 4
antineoplastic agents - therapeutic use (4) 4
bortezomib (4) 4
erythropoiesis (4) 4
fertilisers (4) 4
genetics, population (4) 4
haplotypes (4) 4
janus kinase 2 - genetics (4) 4
leukemia (4) 4
lymphoma (4) 4
lymphomas (4) 4
manufacture thereof (4) 4
medicine & public health (4) 4
myeloproliferative neoplasms (4) 4
neoplasm staging (4) 4
orvostudományok (4) 4
primary myelofibrosis (4) 4
safety (4) 4
thrombosis (4) 4
tyrosine kinase jak2 (4) 4
young adult (4) 4
acute-leukemia (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomedicine (3) 3
bone marrow (3) 3
cancer research (3) 3
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (148) 148
Hungarian (49) 49
French (15) 15
German (8) 8
Norwegian (2) 2
Portuguese (2) 2
Czech (1) 1
Polish (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 297 - 311
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 03/2014, Volume 155, Issue 10, pp. 376 - 382
Journal Article
Orvosi hetilap, ISSN 0030-6002, 03/2014, Volume 155, Issue 10, p. 376
The author presents a novel algorithm for anaemia based on the erythrocyte haemoglobin content. The scheme is based on the aberrations of erythropoiesis and... 
Erythropoiesis | Algorithms | Anemia - blood | Humans | Erythrocytes - metabolism | Hemoglobins - metabolism | Anemia, Hypochromic - blood | Nucleic Acids - metabolism | Hemoglobins - biosynthesis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4635 - 4641
Journal Article
International Journal of Hematology, ISSN 0925-5710, 11/2019, Volume 110, Issue 5, pp. 559 - 565
Daratumumab is a human anti-CD38 monoclonal antibody used in the treatment of refractory and relapsed multiple myeloma. We investigated the efficacy and safety... 
Medicine & Public Health | Hematology | Toxicity | Daratumumab | Multiple myeloma | Oncology | Treatment response | Survival | Care and treatment | Refractory materials | Infusion | Renal function | Bortezomib | CD38 antigen | Monoclonal antibodies | Safety
Journal Article
ORVOSI HETILAP, ISSN 0030-6002, 03/2014, Volume 155, Issue 10, pp. 376 - 382
The author presents a novel algorithm for anaemia based on the erythrocyte haemoglobin content. The scheme is based on the aberrations of erythropoiesis and... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | hypochromic anemia | reticulocyte | IRON | erythropoiesis | PREVALENCE | qualitativ blood smear | hyperchromic anemia | normochromic anemia
Journal Article
by Robak, Tadeusz and Jin, Jie and Pylypenko, Halyna and Verhoef, Gregor and Siritanaratkul, Noppadol and Drach, Johannes and Raderer, Markus and Mayer, Jiri and Pereira, Juliana and Tumyan, Gayane and Okamoto, Rumiko and Nakahara, Susumu and Hu, Peter and Appiani, Carlos and Nemat, Sepideh and Cavalli, Franco and Van Hoof, Achiel and Sheliga, Adriana and Teixeira, Adriana and Tomita, Akihiro and Rocafiguera, Albert Oriol and Suvorov, Alexander and Kuzmin, Alexy and Khojasteh, Ali and Mezlini, Amel and Golenkov, Anatoly and Bosly, Andre and Belch, Andrew and Van De Velde, Ann and Illes, Árpád and Mukhopadhyay, Ashis and Meddeb, Balkis and De Prijck, Bernard and Garichochea, Bernardo and Undar, Bulent and Gabarrón, Caballero and Cao, Carmen and Souza, Carmino and Farber, Charles and Won Suh, Cheol and Burcoveanu, Cristina Ileana and Cebotaru, Cristina Ligia and Truica, Cristina-Ligia and Maruyama, Dai and Belada, David and Ben Yehuda, Dina and Udovitsa, Dmitry and Dolores and Morra, Enrica and Späth-Schwalbe, Ernst and Gonzalez-Barca, Eva and Osmanov, Evgenii and Capote, Francisco Javier and Offner, Fritz and Cardenas, Galvez and Heß, Georg and Manikhas, Georgii and Babu, Govind and Rekhtman, Grigoriy and Rossi, Guiseppe and Marques, Herlander and Marques, Margarida and Bumbea, Horia and Wang, Zhao and Wang, Huaqing and Huang, Huiqiang and Choi, Ilseung and Bulavina, Irina and Lysenko, Irina and Avivi, Irit and Kryachok, Iryna and Zaucha, Jan Maciej and Novak, Jan and Díaz, Joaquín and Demeter, Judit and Alexeeva, Julia and Zhu, Jun and Vilchevskaya, Kateryna and Ishizawa, Kenichi and Mauricio, Kenny and Tobinai, Kensei and Ando, Kiyoshi and Abdulkadryrov, Kudrat and Shih, Lee-Yung and Kuzina, Lyudmila and Gumus, Mahmut and De Wit, Maike and Capra, Marcelo and Golubeva, Marina and Ojeda-Uribe, Mario and Kyselyova, Maryna and Taniwaki, Masafumi and Federico, Massimo and Crump, Michael and Baccarani, Michele and Ogura, Michinori and Egyed, Miklós and Udvardy, Miklos and Kurosawa, Mitsutoshi and Uike, Naokuni and ... and LYM-3002 investigators
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1449 - 1458
In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab,... 
NON-INFERIORITY | TRIAL | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | MULTICENTER | NETWORK | MANAGEMENT | ONCOLOGY | PLUS RITUXIMAB | GUIDELINES | INDOLENT | Anthracyclines | Cyclophosphamide | Corticosteroids | Bortezomib | Analysis | Prednisone | Steroids
Journal Article
Journal Article
by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 08/2018, Volume 159, Issue 33, pp. 1368 - 1371
Journal Article
Orvosi hetilap, ISSN 0030-6002, 01/2017, Volume 158, Issue 3, p. 111
In order to establish and use a national registry, several Hungarian hematology centers collected data of myeloproliferative neoplasia patients. The recent... 
Hungary | Quinazolines - therapeutic use | Humans | Myeloproliferative Disorders - epidemiology | Female | Male | Registries | Myeloproliferative Disorders - drug therapy | Platelet Aggregation Inhibitors - therapeutic use | Philadelphia Chromosome
Journal Article